glp-1 mean Agonists - What is it? Glucagon-like peptide 1 (GLP-1) -

Many patients experience modest weight loss while taking it, though it is not officially approved for obesity treatment

The findings deliver early evidence that semaglutide may offer a dual benefit, targeting obesity and key reproductive challenges associated with the condition, including irregular menstruation and impaired fertility. Clare Thompson, MBBS, BSc, nMRCGP Separately, a review of five randomized controlled trials presented at ENDO 2026 found that GLP-1 drugs, such as semaglutide and liraglutide, do not appear to harm male fertility and may even improve testosterone levels and sperm quality in some men with obesity

49 Further evaluation on a double-blind, randomized phase 1 clinical trial in 98 patients with T2DM on current management with metformin revealed that Danuglipron was generally well tolerated and associated with minimal side effects such as nausea, dyspepsia, and vomiting comparable with the ones observed with the use of injectable GLP-1RA

Endocrinology 166 (4), bqaf028

This single-injection drug based on hydrogel, showed the potential to substantially decrease the need for treatment, thereby enhancing patient well-being and mitigating diabetes management challenges

Research suggests that FOS-induced GLP-1 release may help diabetic rats with insulin secretion and hypoglycemia